Long Noncoding RNAs: Clarity or Confusion?
Because They Are Such Elusive Prey, lncRNAs Have Yet to Emerge as Therapeutic Targets
Markets Expand for Single-Use Bioreactors
Biobags Offer Advantages Over Fixed-Tank Systems
The Challenges of Harmonizing Biomarker Data
Why Trial Success Depends on It
Top 10 Wall Street Losers of 2016
These Companies Lost the Most in a Down Year for Biopharma Stocks
For full access to this article login to GEN Select now.
New Insights into Solid Tumor Cancers
Whole Genome Copy Number Analyses Reveal Novel Druggable Targets
- The first-line treatment for cancer treatment is usually surgery, with many patients also receiving radiation and chemotherapy. However, chemotherapy has significant side effects, and benefits may be short lived with many patients becoming therapy-resistant. As a result, pharmaceutical researchers and oncologists are increasingly using a personalized medicine approach to ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.